drugset / Trial / NCT00726414

A Relative Bioavailability Study of Quinine Sulfate Capsules 324mg

NCT00726414

Phase 1 Completed 22 enrolled Mutual Pharmaceutical Company, Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to evaluate and compare the relative bioavailability of Quinine Sulfate capsules following a single, oral dose in healthy volunteers under fasting and fed conditions.

Timeline

Start
2005-12
Primary completion
2005-12
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Quinine Small molecule 648 mg Oral

Indications

No indication recorded.